sofosbuvir (sovaldi) Report issue

Small molecule Approved FDA First in Class Fast Track FDA Priority Review FDA

Back

Chemistry

Mol. Mass

529.4525

ALogP

1.66

Rule of 5

No

Rule of 3

No
Details
  • SMILES: CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3
  • InChIKey: TTZHDVOVKQGIBA-IQWMDFIBSA-N
    1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1
  • Chirality: Single Stereoisomer
  • Inorganic: No
  • Polymer: No

Sources

CHEMBL1259059   ChEMBL
sofosbuvir

WJ6CA3ZU8B   NCATS
sofosbuvir *

Sofosbuvir   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue